Financial News
2seventy bio, Inc. - Common Stock (NQ: TSVT )
4.390
-0.080
(-1.79%)
Streaming Delayed Price
Updated: 12:22 PM EDT, Jul 22, 2024
Add to My Watchlist
All News about 2seventy bio, Inc. - Common Stock
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230906610874/en/1257457/22/2seventy_logo_for_BW.jpg)
2seventy bio to Participate in the 2023 Morgan Stanley Global Healthcare Conference
September 06, 2023
From 2seventy bio, Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
Analyst Expectations for 2seventy bio's Future
August 15, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Where 2seventy bio Stands With Analysts
July 28, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_1210.jpeg?width=1200&height=800&fit=crop)
2seventy bio: Q1 Earnings Insights
May 03, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/08/17/image23.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/08/15/image22.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/08/15/paysafe_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230814766402/en/1257457/22/2seventy_logo_for_BW.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230807521437/en/1257457/22/2seventy_logo_for_BW.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230801285816/en/1257457/22/2seventy_logo_for_BW.jpg)
From 2seventy bio
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/06/20/aclx.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/06/17/seattle_childrens_hospital.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/06/14/tsvt.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2018/04/stock-biotech-16-adobe.jpg)
![](https://mms.businesswire.com/media/20230614964229/en/1257457/22/2seventy_logo_for_BW.jpg)
![](https://mms.businesswire.com/media/20230607005515/en/1257457/22/2seventy_logo_for_BW.jpg)
From 2seventy bio, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20230519005091/en/1257457/22/2seventy_logo_for_BW.jpg)
![](https://mms.businesswire.com/media/20230517005230/en/1257457/22/2seventy_logo_for_BW.jpg)
![](/next-assets/images/schema-image-default.png)
![](https://mms.businesswire.com/media/20230511005642/en/1257457/22/2seventy_logo_for_BW.jpg)
![](https://mms.businesswire.com/media/20230503005950/en/1257457/22/2seventy_logo_for_BW.jpg)
![](https://mms.businesswire.com/media/20230502006202/en/1257457/22/2seventy_logo_for_BW.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.